Dr. Vivek T.

Dr. Vivek T. has extensive work experience in the pharmaceutical industry. Dr. Vivek is currently the Executive Medical Director at Prevail Therapeutics, starting in September 2022. Prior to this, they worked at Novartis Oncology as the Medical Director, Global Program Safety Leader from September 2019 to July 2022, and as the Senior Pharmacovigilance Leader from April 2017 to September 2019. Before Novartis, they held various positions at Johnson & Johnson, including Associate Director, Signal Management Physician from September 2016 to April 2017, Associate Director, Safety Surveillance Physician from June 2014 to August 2016, and Associate Medical Director, Single Case Analysis Physician from September 2011 to June 2014. Dr. Vivek also worked at Novartis as a Global Medical Safety Physician from June 2010 to September 2011 and as a Senior Clinical Manager (Data Management) from April 2008 to June 2010. Dr. Vivek'scareer started at Boehringer Ingelheim Pharmaceuticals as a Clinical Manager (Data Management) from September 2004 to April 2008.

Dr. Vivek T. holds a MPH degree in Epidemiology from the University of Alabama at Birmingham. Prior to this, they obtained a MBBS/ MD degree in Medicine and Surgery from Mumbai University Mumbai. However, the specific start and end years for both degrees are not provided.